Loading...
280 Use of Omalizumab in Chronic Moderate to Severe Persistent Asthma-an Indian Experience
BACKGROUND: The worldwide prevalence of asthma is high and increasing. In India prevalence of asthma is variable from 4% to 20%. Despite ICS plus LABA therapy 72% of asthma patients were uncontrolled or not well controlled in INSPIRE study. Immunoglobulin-E plays a central role in inflammatory casca...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
World Allergy Organization Journal
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3512853/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000412037.69878.04 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|